# US 2025/0032673 A1 · Bone repair composition and kit

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0032673 A1
- Document ID: US20250032673A1
- Status: Published application
- Kind: A1
- Application number: 18/917,586
- Filed: 2024-10-16
- Published: 2025-01-30
- Earliest claimed: 2018-12-21
- Assignees: Zavation Medical Products, LLC
- Applicants: Zavation Medical Products, LLC
- Inventors: Jeffrey Johnson; Nels J Lauritzen; Brent Mitchell
- Web page: https://patentgrep.com/patent/US20250032673A1

## CPC

- A61L 27/3847: {Bones}
- A61F 2/28: Bones
- A61L 27/10: Ceramics or glasses
- A61L 27/12: Phosphorus-containing materials, e.g. apatite
- A61L 27/24: Collagen
- A61L 27/26: Mixtures of macromolecular compounds
- A61L 27/54: Biologically active materials, e.g. therapeutic substances {(A61L27/227 takes precedence)}
- C04B 35/447: based on phosphates {, e.g. hydroxyapatite}
- A61F 2002/2817: {Bone stimulation by chemical reactions or by osteogenic or biological products for enhancing ossification, e.g. by bone morphogenetic or morphogenic proteins [BMP] or by transforming growth factors [TGF]}
- A61F 2002/2835: {Bone graft implants for filling a bony defect or an endoprosthesis cavity, e.g. by synthetic material or biological material}
- A61F 2002/2839: {Bone plugs or bone graft dowels}
- A61F 2310/00371: Collagen
- A61L 2/081: Gamma radiation
- A61L 2/28: Devices for testing the effectiveness or completeness of sterilisation or disinfection, e.g. indicators which change colour
- A61L 24/02: containing inorganic materials
- A61L 27/46: with phosphorus-containing inorganic fillers
- A61L 2103/05: Living organisms or biological materials
- A61L 2300/414: Growth factors
- A61L 2400/06: Flowable or injectable implant compositions
- A61L 2430/02: for reconstruction of bones; weight-bearing implants
- C04B 2235/3212: Calcium phosphates, e.g. hydroxyapatite
- C04B 2235/36: Glass starting materials for making ceramics, e.g. silica glass
- C04B 2235/5427: millimeter or submillimeter sized, i.e. larger than 0,1 mm
- C04B 2235/9661: Colour
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)
- C04B: LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE {(roofing granules E04D7/005)}; CERAMICS (devitrified glass-ceramics C03C10/00); REFRACTORIES; TREATMENT OF NATURAL STONE

## Abstract

A biocompatible material for bone repair is described. The bone repair composition includes a mixture of a type I collagen, a type I collagen-glycosaminoglycan coprecipitate, tricalcium phosphate; and bioactive glass. Methods of using the composition for bone repair, and a kit for the bone repair composition are also described.

## Claims

### Claim 1

A method for producing a bone repair composition, comprising:
adding collagen to an acid to form a first collagen mixture comprising a collagen dispersion;
thereafter, adding a bone growth stimulator and a bioactive glass to the first collagen mixture and thereby forming a second collagen mixture;
adding the second collagen mixture to a mold;
freeze-drying the second collagen mixture in the mold to remove water therefrom, thereby forming a collagen composition of the collagen, the bone growth stimulator, and the bioactive glass;
cross-linking the collagen composition after removing the collagen composition from the mold, and thereby forming a cross-linked collagen composition of the collagen, the bone growth stimulator, and the bioactive glass;
packaging the cross-linked collagen composition to form a packaged bone repair composition of the collagen, the bone growth stimulator, and the bioactive glass; and
sterilizing the packaged bone repair composition.

### Claim 2 (depends on 1)

The method of claim 1, wherein the collagen in the cross-linked collagen composition ranges from 0.5% to 20% by weight.

### Claim 3 (depends on 1)

The method of claim 1, wherein the collagen in the cross-linked collagen composition comprises particles or flakes which are milled to pass through a 2000 micron mesh.

### Claim 4 (depends on 1)

The method of claim 1, wherein the cross-linked collagen composition as formulated contains no hydroxyapatite.

### Claim 5 (depends on 1)

The method of claim 1, wherein the adding collagen to an acid comprises mixing together the collagen, lactic acid, and water to form the collagen dispersion.

### Claim 6 (depends on 5)

The method of claim 5, wherein the adding collagen to an acid comprises forming a minority percentage of collagen in the dispersion.

### Claim 7 (depends on 6)

The method of claim 6, wherein the minority percentage of collagen in the dispersion comprises 0.85% percentage.

### Claim 8 (depends on 5)

The method of claim 5, further comprising:
after the mixing, resting the first collagen mixture comprising the collagen dispersion in a refrigerator for a first period of time; and
after the first period of time, blending the first collagen mixture comprising the collagen dispersion.

### Claim 9 (depends on 8)

The method of claim 8, wherein, after the blending of the first collagen mixture comprising the collagen dispersion, adding the bone growth stimulator and the bioactive glass to the collagen dispersion.

### Claim 10 (depends on 1)

The method of claim 1, wherein the collagen comprises a type I collagen.

### Claim 11 (depends on 1)

The method of claim 1, wherein the collagen comprises a type I collagen-glycosaminoglycan coprecipitate.

### Claim 12 (depends on 1)

The method of claim 1, wherein the bone growth stimulator particles have a size from 250 to 2500 microns.

### Claim 13 (depends on 1)

The method of claim 1, wherein the bioactive glass particles have a size from 250 to 2500 microns.

### Claim 14 (depends on 1)

The method of claim 1, wherein the bioactive glass ranges from 15% to 25% by weight of the cross-linked collagen composition.

### Claim 15 (depends on 1)

The method of claim 1, wherein the bone growth stimulator comprises tri-calcium phosphate ranging from 75% to 85% by weight of the bone repair composition.

### Claim 16 (depends on 1)

The method of claim 1, wherein the collagen ranges from 0.5% to 20% by weight of the bone repair composition.

### Claim 17 (depends on 1)

The method of claim 1, wherein the freeze-drying produces for the collagen composition a porous product of the of the collagen, the bone growth stimulator, and the bioactive glass.

### Claim 18 (depends on 17)

The method of claim 17, wherein the cross-linking the collagen composition comprises cross-linking the porous product of the of the collagen, the bone growth stimulator, and the bioactive glass.

### Claim 19 (depends on 1)

The method of claim 1, wherein packaging the cross-linked collagen composition comprises:
packaging the cross-linked collagen composition as a rectangular strip; and
placing the rectangular strip in a tray having one or more grip regions to facilitate access to the rectangular strip.

### Claim 20 (depends on 1)

The method of claim 1, wherein the cross-linking comprises:
cross-lining the collagen composition by exposing the collagen composition to formaldehyde vapors released from an airstone containing a formaldehyde solution.
